medica 16 has been researched along with 2,4-thiazolidinedione in 1 studies
| Studies (medica 16) | Trials (medica 16) | Recent Studies (post-2010) (medica 16) | Studies (2,4-thiazolidinedione) | Trials (2,4-thiazolidinedione) | Recent Studies (post-2010) (2,4-thiazolidinedione) |
|---|---|---|---|---|---|
| 35 | 0 | 4 | 798 | 33 | 294 |
| Protein | Taxonomy | medica 16 (IC50) | 2,4-thiazolidinedione (IC50) |
|---|---|---|---|
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | 0.54 | |
| Lysosomal alpha-glucosidase | Homo sapiens (human) | 0.54 | |
| Sucrase-isomaltase, intestinal | Homo sapiens (human) | 0.54 | |
| Probable maltase-glucoamylase 2 | Homo sapiens (human) | 0.54 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flodgren, E; Kotarsky, K; Nilsson, NE; Olde, B; Owman, C | 1 |
1 other study(ies) available for medica 16 and 2,4-thiazolidinedione
| Article | Year |
|---|---|
A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs.
Topics: Aequorin; Animals; Calcium; Cell Line; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Genes, Reporter; Humans; Hypoglycemic Agents; Islets of Langerhans; Mice; Palmitic Acids; Receptors, Cell Surface; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors; Tissue Distribution | 2003 |